Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP458174.RAkQYo3z_1edEv1wmx11ISHahhLZ9Ht410YkWxEnANEOs130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458174.RAkQYo3z_1edEv1wmx11ISHahhLZ9Ht410YkWxEnANEOs130_provenance.
• NP753622.RAsy8KRrD33nOQaWWPWzmk0qyRHfnZIZJvR5l1jKbYE70130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753622.RAsy8KRrD33nOQaWWPWzmk0qyRHfnZIZJvR5l1jKbYE70130_provenance.
• assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549346.RA4qDz2cXmQumvz67dfHEsRhqHXEToOuTB-aSRLjrbXf0130_provenance.
• assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1086187.RAAgUYY4nmyRFnoPhLIgwuAH3A55NmcPeKYxRfes5ZmA8130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086187.RAAgUYY4nmyRFnoPhLIgwuAH3A55NmcPeKYxRfes5ZmA8130_provenance.
• NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765082.RAjwPO3_QTG9vDhx0zwKcv5qidJL7qa5MrqtrYps9h1aE130_provenance.
• NP317646.RA7FqRVFi-oSjuxw7ktfoDDKBdWwiALdJvXxZmPgcQZrw130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317646.RA7FqRVFi-oSjuxw7ktfoDDKBdWwiALdJvXxZmPgcQZrw130_provenance.
• NP387556.RAKveT6NPPlHrRuMSXFKPJajRaViIWWTzvrKKUF0ZmPZA130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387556.RAKveT6NPPlHrRuMSXFKPJajRaViIWWTzvrKKUF0ZmPZA130_provenance.
• NP1086186.RAP9QjfKhkL_H1kOp07_HdhHW7GewAPxd0yGQTH_suQhs130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086186.RAP9QjfKhkL_H1kOp07_HdhHW7GewAPxd0yGQTH_suQhs130_provenance.
• NP1086184.RA6F-TzHX41ym_0kXDwspxitmsfNZCzXoNtr9uEzqXXYU130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086184.RA6F-TzHX41ym_0kXDwspxitmsfNZCzXoNtr9uEzqXXYU130_provenance.
• NP1086185.RA3KWIq-WRFnSbbEL8_DAynMHwQJGia0Yw3Lku0CyKpIM130_assertion description "[Arsenic trioxide (ATO) known to act as an antileukemic agent for acute promyelocytic leukemia (APL) not only enhanced EVI1 sumoylation but also enhanced the co-localization of EVI1 and SUMO1 in nuclear bodies distinct from PML nuclear bodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086185.RA3KWIq-WRFnSbbEL8_DAynMHwQJGia0Yw3Lku0CyKpIM130_provenance.